Log in
Enquire now
‌

US Patent 9988429 Glucagon analogues

Patent 9988429 was granted and assigned to Zealand Pharma A/S on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Zealand Pharma A/S
Zealand Pharma A/S
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99884290
Patent Inventor Names
Dieter Wolfgang Hamprecht0
Jakob Lind Tolborg0
Ditte Riber0
Date of Patent
June 5, 2018
0
Patent Application Number
145162160
Date Filed
October 16, 2014
0
Patent Citations Received
‌
US Patent 11884713 Acylated glucagon analogues
0
Patent Primary Examiner
‌
Gyan Chandra
0
Patent abstract

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9988429 Glucagon analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us